After failing to negotiate new deals in 2004, Geneva-based proteomics outfit GeneProt has decided to close its doors. Keith Rose, the company’s former CSO, says GeneProt had not run out of cash but was shutting its doors “because closing down was seen as the best way to preserve and not squander the remaining resources.”
Full-text access for registered users only.
Existing users login here
New to GenomeWeb? Register here
quickly for free access.